The effect and mechanism of hexokinase‐2 on cisplatin resistance in lung cancer cells A549
Environmental Toxicology · 2024-05 · 39 (5) · 2667-2680
DOI: 10.1002/tox.24140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 15.01.2024. Verfasst von Shishun Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Natural Science Foundation of Jilin Province.
Abstract (Originalsprache)
Background
Hexokinase (HK) is the first rate‐limiting enzyme of glycolysis, which can convert glucose to glucose‐6‐phosphate. There are several subtypes of HK, including HK2, which is highly expressed in a variety of different tumors and is closely associated with survival.
Methods
Non‐small cell lung cancer (NSCLC) A549 cells with stable overexpression and knockdown of HK2 were obtained by lentivirus transfection. The effects of overexpression and knockdown of HK2 on proliferation, migration, invasion, and glycolytic activity of A549 cells were investigated. The effects on apoptosis were also analyzed using western blot and flow cytometry. In addition, the mitochondria and cytoplasm were separated and the expression of apoptotic proteins was detected by western blot respectively.
Results
Upregulation of HK2 could promote glycolysis, cell proliferation, migration, and invasion, which would be inhibited through the knockdown of HK2. HK2 overexpression contributed to cisplatin resistance, whereas HK2 knockdown enhanced cisplatin‐induced apoptosis in A549 cells.
Conclusions
Overexpression of HK2 can promote the proliferation, migration, invasion, and drug resistance of A549 cells by enhancing aerobic glycolysis and inhibiting apoptosis. Reducing HK2 expression or inhibiting HK2 activity can inhibit glycolysis and induce apoptosis in A549 cells, which is expected to be a potential treatment method for NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, Changchun, China.
- Department of Respiratory medicine, China-Japan Union Hospital of Jilin University, Changchun, China.
- General Surgery Center, Department of Breast Surgery, The First Hospital of Jilin University, Changchun, China.
ORCID-Profile: Shaomin Shi
Förderung
- Natural Science Foundation of Jilin Province
Zitieren
APA
Xie, S., Li, X., Zhao, J., Zhang, F., Shu, Z., Cheng, H., Liu, S., & Shi, S. (2024). The effect and mechanism of hexokinase‐2 on cisplatin resistance in lung cancer cells A549. Environmental Toxicology, 39(5), 2667-2680. https://doi.org/10.1002/tox.24140
Vancouver
Xie S, Li X, Zhao J, Zhang F, Shu Z, Cheng H, et al. The effect and mechanism of hexokinase‐2 on cisplatin resistance in lung cancer cells A549. Environmental Toxicology. 2024;39(5):2667-2680. doi:10.1002/tox.24140
BibTeX
@article{Xie2024,
author = {Xie, Shishun and Li, Xiangjun and Zhao, Jianjun and Zhang, Fan and Shu, Zhiyun and Cheng, Hongyuan and Liu, Siyao and Shi, Shaomin},
title = {The effect and mechanism of hexokinase‐2 on cisplatin resistance in lung cancer cells A549},
journal = {Environmental Toxicology},
year = {2024},
volume = {39},
number = {5},
pages = {2667--2680},
doi = {10.1002/tox.24140}
}
EUVIMED